Status:
UNKNOWN
Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Collaborating Sponsors:
Fondation de l'Avenir
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Patients with irritable bowel syndrome (IBS) have increased intestinal permeability. In addition, mucosal soluble mediators are involved in the pathophysiology of pain in IBS. The investigators aimed ...
Eligibility Criteria
Inclusion
- Patients needing coloscopy
Exclusion
- Disrupted coagulation results
- Cancer even healed
- Known food allergy.
- Alcohol consumption \>30g/day
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00742118
Start Date
February 1 2008
End Date
July 1 2016
Last Update
September 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of gastroenterology, Hopital Archet 2
Nice, France, 06002